Sectors

The CreditEase-backed banking services provider is targeting a 2021 initial public offering following a round co-led by V Capital and Shefa Capital.

Otsuka Pharmaceuticals's McQuade Center for Strategic Research and Development backed the psilocybin-based mental health drug developer through the round.

Repeatome drug developer Rome Therapeutics was incubated within GV, which took part in the series A round along with fellow corporate unit Partners Innovation Fund.

The robotics AI technology developer pulled in $36m through a series D round led by SoftBank Vision Fund that included fellow existing investor Qualcomm Ventures.

The coffee chain has selected Sequoia Capital China as its partner for a strategic investment campaign in one of its two largest growth markets.

Qualcomm Ventures and Xiaomi helped the display chip provider secure $28.3m in a combined series C and C-plus round.

Terese Hougaard has taken a principal role at the UK-based venture firm after five years at Alphabet unit CapitalG, most recently as a partner.

The consumer and business finance provider was reportedly valued at more than $1bn in an equity investment by video game publisher Nexon.

GLP and G7 - two of the three corporates that co-founded autonomous fleet software developer Inceptio - have contributed to its series A round.

Cancer therapy developer Oric, whose backers include Memorial Sloan, Taiho and Hartford HealthCare, floated at the top of its range in an expanded IPO.

The potential investment would potentially be added to the $1bn series G round disclosed by the mobile financial services provider in November.